198 related articles for article (PubMed ID: 19549893)
1. Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
Pomerantz MM; Beckwith CA; Regan MM; Wyman SK; Petrovics G; Chen Y; Hawksworth DJ; Schumacher FR; Mucci L; Penney KL; Stampfer MJ; Chan JA; Ardlie KG; Fritz BR; Parkin RK; Lin DW; Dyke M; Herman P; Lee S; Oh WK; Kantoff PW; Tewari M; McLeod DG; Srivastava S; Freedman ML
Cancer Res; 2009 Jul; 69(13):5568-74. PubMed ID: 19549893
[TBL] [Abstract][Full Text] [Related]
2. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy.
Whitman EJ; Pomerantz M; Chen Y; Chamberlin MM; Furusato B; Gao C; Ali A; Ravindranath L; Dobi A; Sesterhenn IA; McLeod DG; Srivastava S; Freedman M; Petrovics G
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):1-8. PubMed ID: 20056617
[TBL] [Abstract][Full Text] [Related]
4. 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.
Fromont G; Godet J; Peyret A; Irani J; Celhay O; Rozet F; Cathelineau X; Cussenot O
Hum Pathol; 2013 Aug; 44(8):1617-23. PubMed ID: 23574779
[TBL] [Abstract][Full Text] [Related]
5. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.
Wasserman NF; Aneas I; Nobrega MA
Genome Res; 2010 Sep; 20(9):1191-7. PubMed ID: 20627891
[TBL] [Abstract][Full Text] [Related]
6. 8q24 allelic imbalance and MYC gene copy number in primary prostate cancer.
Chen H; Liu W; Roberts W; Hooker S; Fedor H; DeMarzo A; Isaacs W; Kittles RA
Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):238-43. PubMed ID: 20634801
[TBL] [Abstract][Full Text] [Related]
7.
Barry KH; Mohanty K; Erickson PA; Wang D; Shi J; Rose G; Cellini A; Clark K; Ambulos N; Yin J; Yan L; Poulin M; Meyer A; Zhang Y; Bentzen SM; Burke A; Hussain A; Berndt SI
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374332
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer risk alleles are associated with prostate cancer volume and prostate size.
Reinhardt D; Helfand BT; Cooper PR; Roehl KA; Catalona WJ; Loeb S
J Urol; 2014 Jun; 191(6):1733-6. PubMed ID: 24345439
[TBL] [Abstract][Full Text] [Related]
9. Racial disparities in the association between variants on 8q24 and prostate cancer: a systematic review and meta-analysis.
Troutman SM; Sissung TM; Cropp CD; Venzon DJ; Spencer SD; Adesunloye BA; Huang X; Karzai FH; Price DK; Figg WD
Oncologist; 2012; 17(3):312-20. PubMed ID: 22382457
[TBL] [Abstract][Full Text] [Related]
10. Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders.
Glinskii AB; Ma S; Ma J; Grant D; Lim CU; Guest I; Sell S; Buttyan R; Glinsky GV
Cell Cycle; 2011 Oct; 10(20):3571-97. PubMed ID: 22067658
[TBL] [Abstract][Full Text] [Related]
11. Statistical recombinant mapping in extended high-risk Utah pedigrees narrows the 8q24 prostate cancer locus to 2.0 Mb.
Camp NJ; Farnham JM; Allen-Brady K; Cannon-Albright LA
Prostate; 2007 Sep; 67(13):1456-64. PubMed ID: 17654497
[TBL] [Abstract][Full Text] [Related]
12. Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility.
Solé X; Hernández P; de Heredia ML; Armengol L; Rodríguez-Santiago B; Gómez L; Maxwell CA; Aguiló F; Condom E; Abril J; Pérez-Jurado L; Estivill X; Nunes V; Capellá G; Gruber SB; Moreno V; Pujana MA
BMC Genomics; 2008 Jan; 9():12. PubMed ID: 18190704
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome.
Du M; Yuan T; Schilter KF; Dittmar RL; Mackinnon A; Huang X; Tschannen M; Worthey E; Jacob H; Xia S; Gao J; Tillmans L; Lu Y; Liu P; Thibodeau SN; Wang L
Hum Mol Genet; 2015 Jan; 24(1):154-66. PubMed ID: 25149474
[TBL] [Abstract][Full Text] [Related]
14. Association of 8 loci on chromosome 8q24 with prostate carcinoma risk in northern Chinese men.
Zhao CX; Liu M; Wang JY; Xu Y; Wei D; Yang K; Yang Z
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6733-8. PubMed ID: 24377597
[TBL] [Abstract][Full Text] [Related]
15. Germline variation at 8q24 and prostate cancer risk in men of European ancestry.
Matejcic M; Saunders EJ; Dadaev T; Brook MN; Wang K; Sheng X; Olama AAA; Schumacher FR; Ingles SA; Govindasami K; Benlloch S; Berndt SI; Albanes D; Koutros S; Muir K; Stevens VL; Gapstur SM; Tangen CM; Batra J; Clements J; Gronberg H; Pashayan N; Schleutker J; Wolk A; West C; Mucci L; Kraft P; Cancel-Tassin G; Sorensen KD; Maehle L; Grindedal EM; Strom SS; Neal DE; Hamdy FC; Donovan JL; Travis RC; Hamilton RJ; Rosenstein B; Lu YJ; Giles GG; Kibel AS; Vega A; Bensen JT; Kogevinas M; Penney KL; Park JY; Stanford JL; Cybulski C; Nordestgaard BG; Brenner H; Maier C; Kim J; Teixeira MR; Neuhausen SL; De Ruyck K; Razack A; Newcomb LF; Lessel D; Kaneva R; Usmani N; Claessens F; Townsend PA; Gago-Dominguez M; Roobol MJ; Menegaux F; Khaw KT; Cannon-Albright LA; Pandha H; Thibodeau SN; Schaid DJ; ; Wiklund F; Chanock SJ; Easton DF; Eeles RA; Kote-Jarai Z; Conti DV; Haiman CA
Nat Commun; 2018 Nov; 9(1):4616. PubMed ID: 30397198
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of DNA methylation at chromosome 8q24 in peripheral blood and prostate cancer risk.
Barry KH; Moore LE; Sampson JN; Koutros S; Yan L; Meyer A; Reddy M; Oler AJ; Cook MB; Fraumeni JF; Yeager M; Amundadottir LT; Berndt SI
Br J Cancer; 2017 May; 116(11):1470-1479. PubMed ID: 28463958
[TBL] [Abstract][Full Text] [Related]
18. 8q24 and prostate cancer: association with advanced disease and meta-analysis.
Cheng I; Plummer SJ; Jorgenson E; Liu X; Rybicki BA; Casey G; Witte JS
Eur J Hum Genet; 2008 Apr; 16(4):496-505. PubMed ID: 18231127
[TBL] [Abstract][Full Text] [Related]
19. [Association of chromosome 8q24 variants with prostate cancer risk in the Siberian region of Russia and meta-analysis].
Os'kina NA; Boiarskikh UA; Lazarev AF; Petrova VD; Ganov DI; Tonacheva OG; Lifshits GI; Filipenko ML
Mol Biol (Mosk); 2012; 46(2):234-41. PubMed ID: 22670519
[TBL] [Abstract][Full Text] [Related]
20. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility.
Chung S; Nakagawa H; Uemura M; Piao L; Ashikawa K; Hosono N; Takata R; Akamatsu S; Kawaguchi T; Morizono T; Tsunoda T; Daigo Y; Matsuda K; Kamatani N; Nakamura Y; Kubo M
Cancer Sci; 2011 Jan; 102(1):245-52. PubMed ID: 20874843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
